05/08/2024 | Press release | Distributed by Public on 05/08/2024 06:50
Hearings, Meetings, Proceedings, etc.: Peripheral and Central Nervous System Drugs Advisory Committee, Biologics License Application for Donanemab Solution for Intravenous Infusion
